US2019024167A1PendingUtilityA1

Primers and methods for the detection and discrimination of nucleic acids

72
Assignee: LIFE TECHNOLOGIES CORPPriority: Oct 23, 2001Filed: Jun 28, 2018Published: Jan 24, 2019
Est. expiryOct 23, 2021(expired)· nominal 20-yr term from priority
C12Q 1/686C12Q 1/6869C12P 19/34C12Q 2525/161C12Q 2565/107C12Q 1/6816C12Q 1/6827C12Q 2563/107G01N 21/6486C12Q 2525/121C12Q 1/6876
72
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The present invention provides novel primers and methods for the detection of specific nucleic acid sequences. The primers and methods of the invention are useful in a wide variety of molecular biology applications and are particularly useful in allele specific PCR.

Claims

exact text as granted — not AI-modified
1 .- 74 . (canceled) 
     
     
         75 . A composition comprising at least one nucleic acid molecule and at least two oligonucleotides, wherein at least a portion of said first and second oligonucleotides are capable of hybridizing with at least a portion of said nucleic acid molecule and wherein said first and second oligonucleotides each comprise at least one modified nucleotide internally and/or at or near the 3′- and/or 5′-terminal nucleotide. 
     
     
         76 . The composition of  claim 75 , wherein said at least one modified nucleotide of said first and/or said second oligonucleotide is a 2′-O-alkyl ribonucleotide. 
     
     
         77 . The composition of  claim 75 , said composition further comprising at least one component selected from the group consisting of one or more nucleotides, one or more DNA polymerases and one or more reverse transcriptases. 
     
     
         78 . The composition of  claim 75 , wherein said modified nucleotide of said first oligonucleotide comprises a detectable label. 
     
     
         79 . The composition of  claim 78 , wherein said detectable label is a fluorescent moiety. 
     
     
         80 . The composition of  claim 79 , wherein said modified nucleotide on said second oligonucleotide is a quencher moiety. 
     
     
         81 . The composition of  claim 80 , wherein said fluorescent moiety and/or said quencher moiety is located at a 3′-terminal nucleotide on said first and/or said second oligonucleotide. 
     
     
         82 . The composition of  claim 80 , wherein said fluorescent moiety and/or said quencher moiety is located at a 5′-terminal nucleotide on said first and/or said second oligonucleotide. 
     
     
         83 . The composition of  claim 75 , wherein said nucleic acid molecule comprises a RNA molecule. 
     
     
         84 . The composition of  claim 75 , wherein said nucleic acid molecule comprises a cDNA molecule. 
     
     
         85 . The composition of  claim 80 , wherein said fluorescent moiety and said quencher moiety comprise a FRET pair. 
     
     
         86 . The composition of  claim 79 , wherein said fluorescent moiety is selected from the group consisting of a nuoresceinphosphoramidite (FAM) moiety, a 6-carboxynuorescein succinimidyl ester (6-FAM, SE) moiety, a nuorescein-5-isothiocyanate (FITC) moiety, a 5-(6-)-carboxytetramethyl rhodamine (TAMRA) moiety, a succinimidyl ester moiety, and a 4,4-dinuoro-5, 7-diphenyl-4-bora-3a,4a-diaza-s-indacene-3-propionic acid (BODIPY 530/550) moiety. 
     
     
         87 . A method for quantitation or detection of one or more target nucleic acid molecules in a nucleic acid sample during nucleic acid amplification comprising:
 mixing said nucleic acid sample with a composition comprising at least two oligonucleotides under conditions sufficient to amplify said one or more target nucleic acid molecules complementary to, all or a portion of a sequence of said target nucleic acid molecule(s), said amplified target nucleic acid molecule(s) comprising said oligonucleotides, wherein said first oligonucleotide comprises a detectable label located internally and/or at or near a 3′- and/or 5′-terminal nucleotide; and   detecting the presence or absence or quantifying the amount of said target nucleic acid molecule(s) by measuring said detectable label of said first oligonucleotide.   
     
     
         88 . The method of  claim 86 , wherein said second oligonucleotide comprises a quencher moiety located internally and/or at or near a 3′- and/or 5′-terminal nucleotide 
     
     
         89 . A kit for use in the synthesis and/or amplification of a target nucleic acid molecule, said kit comprising at least two oligonucleotides, wherein at least a portion of said first and second oligonucleotides are capable of hybridizing with at least a portion of said target nucleic acid molecule and wherein said first and second oligonucleotides each comprise at least one modified nucleotide internally and/or at or near the 3′- and/or 5′-terminal nucleotide. 
     
     
         90 . The kit of  claim 89 , wherein said at least two oligonucleotides are provided in a single composition or mixture of said kit. 
     
     
         91 . The kit of  claim 89 , wherein said modified nucleotide of said first oligonucleotide comprises a detectable label. 
     
     
         92 . The kit of  claim 91 , wherein said detectable label is a fluorescent moiety. 
     
     
         93 . The composition of  claim 92 , wherein said modified nucleotide on said second oligonucleotide is a quencher moiety. 
     
     
         94 . The kit of  claim 93 , wherein said fluorescent moiety and said quencher moiety comprise a FRET pair.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.